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Background: Considering the structural loss that occurs after surgical procedures for cystic and tumoral pathology, 
in periodontitis, as well as the maxillary atrophy that determines the rehabilitation with dental implants, it is impe-
rative to find satisfactory solutions. The opportunity provided by the findings in stem cells is a recent introduction 
in the field of oral surgery, based on the regenerative potential that these cells possess in order to restore defects at 
different levels of the oral cavity. The aim of this systematic review is to discover the real applications that stem 
cells may have in our treatments in the near future. 
Material and Methods: We made a systematic review of the literature on the subject of stem cells to know the 
publications relating to them in the field of oral surgery since 2000. PRISMA statement was accomplished, as its 
official flow chart is used. 
Results: This article draws clinical conclusions from basic research and those conducted in the first clinical cases to 
apply them in a short period of time to our patients in order to achieve excellence in regenerative therapies. 
Conclusions: To summarize, stem cells may be a turning point in tissue regeneration, though the major challenge is 
to overcome the remaining obstacles before they become a realistic therapeutic alternative.




When embryonic stem cells were first identified and 
isolated in mice, it meant a milestone in the history of 
science (1,2). Before, in the 90s of last century, embryo-
nic stem cells had been obtained from primates. In 1998 
the researcher Thomson succeeded for the first time in 
isolating a lineage of embryonic stem cells, obtained 
from the interior of the cellular mass of an embryo in a 
4-7 days blastocyst (3).
First, we consider it necessary to clarify the fundamen-
tal terms used in this systematic review. Stem cells can 
be defined as the cells responsible for of the founda-
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tion of each and every organ and tissue of in the human 
body. They have two defining characteristics (4): ability 
to renew themselves indefinitely, producing new stem 
cells, as well as the ability to differentiate, at the same 
time, into specialized daughter cells which can perform 
specific functions. These two features are governed by 
extracellular signals coupled to intracellular signaling 
cascades. The information that specifies the fate of stem 
cells is encoded by the presence or absence of these sig-
nals, and also for their combination, location, level and 
timing. In general, stem cells can be divided into two 
subtypes: pluripotent and multipotent. The former, also 
known as totipotent, can differentiate into any type of 
cell in the human body. They are also stem cells those 
that are called multipotencial, which can differentiate 
into many different cell types within their lineage. In re-
ference to the origin of stem cells, they can be obtained 
from different sources: from the interior of the mass of 
cells of the blastocyst, prior to the implantation of the 
embryo, together with fetal and adult tissue. To date, six 
types of cells have been isolated mother (5-7) as is sum-
marized in Figure 1.  Found in most human tissues, they 
are delivered from tissues undergoing constant self-re-
novation, as well as other tissues with a lower renewal 
capacity. Being designed to work in tissues in the long 
run, adult stem cells are responsible for their maintenan-
ce and repair by replacing cells which are damaged or 
have been lost. Considering that adult stem cells are ge-
nerally multipotent, they may form a limited number of 
cell types, corresponding to their tissues of origin.
 The presence of adult stem cells (Fig. 2) has been found 
in various tissues. Apart from the bone marrow, which 
is an important source of mesenchymal stem cells, the 
detection of adult stem cells in the oral cavity is nota-
ble, being present in exfoliated deciduous teeth, dental 
pulp and periodontal ligament. These cells represent a 
Fig. 1: Classification of types of human stem cells, according to its origin, cell type and the degree of differentiation that can develop.
population of post-natal stem cells capable of perfor-
ming an extensive proliferation with a multipotent ca-
pacity for differentiation (8). Adult stem cells that reside 
in the mucosa of the oral cavity have a dual capacity, 
both osteogenic and neurogenic. Nevertheless, these cell 
populations of the oral cavity are not completely cha-
racterized, few stem cells have been isolated so far, and 
their markers are still unknown.
Tissue engineering requires the selection of an ideal 
source of stem cells; for which they need to allow se-
veral conditions (9), including the easy access and the 
availability of the donor area, a large capacity of self-re-
newal    or expansion in the place of origin, as well as an 
ability to easily differentiate into cell lineages of interest 
issued by the signaling molecules. In addition, it is es-
sential to prove an absence or minimal immunogenicity 
as well as a minimal risk of malignant transformation 
capacity. Referring to the donor site of stem cells, they 
are usually cultivated from iliac crest bone marrow can-
didates, although the extraction procedure can be painful 
and laborious. It is interesting that mesenchymal stem 
cells can be obtained from the periosteum of the mandi-
ble, accessible to the oral surgeon under local anesthe-
sia, obtaining mesenchymal stem cells of the periosteum 
with a proven osteogenic potential. In addition, it can be 
obtained from the maxillary tuberosity. Samples can be 
cultivated in vivo during a certain period of time, scat-
tered in biomaterial that serves to give structure to the 
cells, and then transplanted into the defect we desire to 
regenerate, as in a sinus lift procedure.
There are products available based on cells obtained 
from bone marrow mesenchymal stem. These products 
contain stem cells suitable to differentiate into various 
cell types, and can respond to the medium where they 
are inserted to differentiate themselves in the appro-
priate tissues, as needed. Moreover, these products can 
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Fig. 2: Different tissues where the existence of adult stem cells have been shown.
be provided to patients without the inconvenience and 
potential complications from obtaining an autologous 
graft. 
Dental practitioners have to deal on many occasions 
with patients´ structure loss in different levels of the oral 
cavity: tooth, periodontal tissue, alveolar bone and soft 
tissue. Scientific investigations have been forced to try 
to find more effective methods to the traditionally used 
to replace lost tissues. In addition to reaching the best 
levels of health and functionality of the oral cavity, the 
dentist is subject to the patients´ needs, primarily see-
king the best aesthetic result conditioned by economic 
aspects.
In this article we will focus on progress in issues of re-
generative therapies that dentists can use in the field of 
oral surgery. The problem that arises is the need to find 
more satisfactory solutions to the loss of structures, as 
occurs after surgeries of cystic and tumor pathologies, in 
maxillary atrophy of the patient partially or totally eden-
tulous, implantology treatments, grafts, etc.
Our main goal is to update on this matter that we consider 
promising, and which from our point of view, dentists 
are not informed enough in order to make these thera-
pies known to their patients. The possibility of access to 
rigorous bibliographic sources gives us the opportunity 
to learn about everything concerning stem cells, which 
is presented as an interesting alternative to the multitude 
of regenerative therapies of doubtful predictability and 
unconvincing results known up to now in oral surgery 
and periodontics.
Material and Methods
The first step for this systematic review of the literature 
on the subject of stem cells was to know the publications 
relating to them in the field of oral surgery. PRISMA 
statement was accomplished, as its official flow chart is 
used. The method used to obtain this information was 
to perform a search of articles in the database PubMed. 
Our search strategy selected the key words “Oral Sur-
gical procedures” (Mesh) AND “Stem Cells” (Mesh). 
More results were obtained including the MeSH terms. 
The eligibility criteria consisted in choosing all the stu-
dies published since 2000, as from that date on it a lar-
ge increase in the production of scientific publications 
in relation to the topic of our search can be observed. 
Also, we excluded articles without English translation 
and those only published on books. In addition to the 
main bibliographical search, other searches of additio-
nal publications (extracted from the reference lists of the 
articles found in the main search in PubMed) have been 
carried out for this paper, as books and articles that did 
not meet the inclusion criteria. 
Then, a full analysis of the texts was conducted. The re-
ason we did not focus on strictly analyzing those studies 
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performed on patients and clinical studies, taking into 
account that the ultimate aim of this work is to find pos-
sible applications of stem cell therapy for our patients, is 
that we consider that there are not sufficient studies on 
humans with powerful statistical evidence; since most 
of the published studies are in the experimental phase or 
are based on clinical cases performed on few patients. 
This should be taken into account because they have a 
design that does not allow extrapolation to the general 
population, and in many cases do not provide statistica-
lly significant results in humans.
For this reason, it was imperative to obtain a wide range 
of studies, both in vitro and in vivo: research, in experi-
ments on animals, as well as studies on patients, regard-
less of the number of subjects tested, and if they used 
control groups or not. Despite being also included, this 
does not mean that all of these features have not been 
taken into account. On the contrary, these data were se-
lected from each of the articles to make a clear statement 
of the results obtained in our search. They were roughly 
two types of articles: primary research articles and re-
views of the literature. 
Results
Figure 3 shows the study selection on a flow diagram, 
with the selection of studies from the search strategy. 
In addition, it reveals how 72 articles from the additio-
nal search were excluded for the principal analysis, as 
well as 17 articles that were excluded after applying ex-
clusion criteria. Studies included in the qualitative syn-
thesis were 53. Of these 53 selected articles, 19 were 
reviews of the literature and were research articles. Of 
the group of primary research articles, 23 studies have 
been conducted on animals. This necessary step prior to 
its application in humans, implies a lower stage on the 
pyramid of scientific evidence compared to studies on 
patients. Our research included an article (10) carried 
out with cells of embryonic origin. Regarding studies 
performed on patients, there were a total of 10 articles. 
Furthermore, all of them used a very small population 
Fig. 3: Flow diagram. Study selection.
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sample: 2 patients (11), 11 patients (12), 1 patient (13), 
3 patients (14), 7 patients (15), 5 patients (16), 7 patients 
(17), 3 patients (18), 3 patients (19) and 3 patients (20).
Discussion
Will these materials work on our patients?
The findings of the different studies draw an affirmati-
ve answer. However, there are still some considerations 
that prevent stem cells from being an adaptable therapy 
for our patients. For instance, in most of the studies 
multiple biomaterials are mentioned to be used along 
with the stem cells. It is known that its utility in the 
majority of cases is to act as a filler”, recovering the 
architecture of the receiving area, without meaning that 
they are able to cause regeneration of the tissues. All 
studies agree that histological evidence is the only way 
to confirm that regeneration has taken place, therefore 
it is necessary to carry out further studies on patients 
(1-5,9,19).  
What are the basic pillars of the cell therapy?
This can be summed up in the triad of the tissue engi-
neering of Nakashima et al (21), which is divided into 
three basic components of biological tissues: the respon-
se of the cells, an extracellular matrix that serves as sca-
ffolding and induction of morphogenetic signals, as the 
BMPs. This triad is essential for the regeneration of the 
oral cavity´s structures. For example, during the process 
of healing with calcium hydroxide paste, the cells that 
respond are the pulp cells that migrate and morphoge-
netic signals are factors of growth, differentiation and 
BMPs, that have been stored in the dentin matrix and 
released at the site of the lesion. In this case oesteodentin 
is the matrix where cells may adhere.
In which surgical procedures could regeneration using 
stem cells be used?
Some of the surgical procedures mentioned in the arti-
cles of our main search, both reviews and research arti-
cles, are:
• Periodontal regeneration (14,22-31) 
• Reconstruction of large bone defects (27,32-33) 
• After respective surgeries of cysts and tumors (13)
• Periapical surgery (34)
• Caused by osteoradionecrosis (35)
• Mandibular distraction (36-37)
• Surgical treatment prior to implants
• Sinus lift (9,12,38)
• Increase of crestal bone and to improve the osseointe-
gration (11,18,39-40)
Also, it has been shown that adult stem cells play a key 
role in the healing of the post extraction sockets (31, 41). 
Despite not being our revision´s issue, there are several 
non-surgical procedures where the use of stem cells is 
proposed, as in dentin regeneration (21, 31). Its use is 
also being fully studied in endodontic therapy, as men-
tioned in a publication (25).
What methods do we have to apply stem cells in oral 
surgery?
There are almost as many methods of applying stem 
cells as studies have been published. This occurs becau-
se there are still no protocols established regarding bio-
materials that should be used for their conduction. The-
refore, every research group proposes its method based 
on previous studies or other publications.
The creation of bone graft from ectopic production is 
frequently mentioned, for instance, to expanse and diffe-
rentiate stem cells in vitro, and subsequently, when the 
appropriate analysis considers that there is a good osteo-
genic activity, said graft is transplanted to the area de-
manding regeneration. Something similar happens with 
the stem cells obtained from blood extraction procedures 
(11) that can be used in treatments prior to rehabilitation 
with dental implants, as in sinus lift (38).
A mixture of autologous stem cells with all kinds of 
bone grafts is also common, as already described in the 
introduction and that the oral surgeon is more than fami-
liar with. They can be used with graft, animal or synthe-
tic origin (23) or autologous (43-44). The use of a fibrin 
gel like material that eases its application is illustrated, 
as in the case of injectable bone (39). The use of an in-
jectable preparation consisting of adult autologous stem 
cells combined with platelet-rich plasma gel is also do-
cumented in a study on dogs (33). Another study which 
suggests the use of platelet-rich plasma is published by 
Ito K et al (40).
The use of biocompatible membranes, especially in the 
case of periapical surgery is a controversial subject. Au-
tologous grafts seem to achieve better results without 
collagen membranes (44). On the other hand, the simple 
application of a membrane with or without bone graft 
for periapical surgery, may not result in a regeneration of 
periapical tissues (34). This is due to the fact that these 
biomaterials are not able to perform the recruitment of 
stem cells or signaling molecules that induce mesenchy-
mal cells to differentiate into pre-osteoblasts, periodon-
tal ligament, and pre-cementoblasts forming cells. The 
beginning of the healing of the periapical lesion after 
periapical surgery is similar to what occurs in a wound 
in the connective tissue in any other part of the body (34-
35). Concerning that this healing ideally means not only 
regeneration of alveolar bone, but also of the periodontal 
ligament and cement after periapical surgery, stem cells 
might achieve complete periapical tissue regeneration, 
as an ideal result of periapical surgery. Therefore, as in 
the post-extraction sockets, the existence of a blood clot 
from the host provides an excellent natural scaffold for 
proper healing of surgical wounds (20,34,41). The same 
happens in studies of mandibular distraction (36-37), 
where the action of stem cells is stimulated due to surgi-
cal technique, or orthopedics in the treatment of mandi-
bular advancement (37).
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There are several materials that are not so frequently 
used in oral surgery but mentioned in certain research 
studies, as β-TCP (46-47), the gelatin chitosan (41), 
poly-lactic-glycolic acid (19) or hydroxyapatite (35). 
These materials are mostly supplemented with grafts, 
and there are studies in which the authors compare 
some materials in study groups to check the differences 
among them.
Does the advanced age of the patients affect to the res-
ponse to treatment with stem cells?
Implant dentistry transformed the possibilities of resto-
ration on edentulous patients that had suffered of bone 
loss. In extreme cases the patients have to go through 
aggressive surgical procedures in order to compensate 
severe jaw atrophies, and many times it is not feasible 
because of the general health of elderly patients. The-
refore, gene therapy is presented as an alternative treat-
ment for these patients. Authors indicate that a possibili-
ty could be cytokine stimulation of stem cells. However, 
the question of whether it is effective to stimulate adult 
stem cells found in these patients, especially in the elder-
ly, is a controversial matter (48).
There is evidence that indicates that aging of the indivi-
dual, together with that of their stem cells´ lineages do 
not respond to the induction of cytokines such as BMP as 
well as it would be desired. Nevertheless, these hypothe-
ses are supported by studies on tissue culture and small 
animal researches; it would be too precipitated to extra-
polate these findings to our patients (32). Indeed, works 
on primates, indicate that despite a loss in the number 
of stem cells with aging, using BMP as surgically im-
planted material seems to promote bone regeneration in 
large mandibular defects. In elderly hominids Macaca 
fascicularis, over 25 years of age, a consistent regene-
ration was proved (49). This is important for the im-
plementation of these cellular therapies in our patients, 
since the majority of patients for reconstruction of the 
alveolar bone are in the older age groups. Count of stem 
cells in the bone marrow and periosteum in patients of 
75 years of age, for example, is valued at approximately 
1 of every 300,000 cells. This decrease in the number of 
cells must be taken into account to produce a minimum 
of response to stimulation with BMP.
What challenges do we have to face in order to use the 
therapy based on the research on stem cell?
Biological challenges
Despite the evidence showing that regeneration can be 
achieved in our patients, the difficult goal of clinically 
achieving a predictable and complete regeneration (as 
occurs in the case of severe periodontal defects pro-
blems) still remains. The isolation and characterization 
of stem cells obtained from periodontal tissues has pro-
vided backing for the understanding of the role of stem 
cells in wound healing of oral tissues.
However, there are many points that we do not unders-
tand at all (27, 35). This happens for example in terms of 
the understanding of signaling mechanisms that dictate 
aspects as they develop of the tooth root. And beyond, 
basic aspects of the behavior of stem cells, the molecular 
basis that dictate the routes which take in their process 
of self-renewal and differentiation are also largely unk-
nown (50). Regarding that regeneration in oral tissues 
does happen, we have to repeat the key cellular events 
that are parallel to the development of such structures, 
and get the different cell types specifically, apply the 
same inductive factors and cellular processes involved 
in the formation of the oral structures to regenerate.
Considering that the final destination of stem cells is 
influenced by their interaction with their biological ni-
che, in other words, with the microenvironment that 
surrounds them (including soluble and immobilized fac-
tors, extracellular matrix, and signals from neighboring 
cells), the understanding of these key components of the 
regulation of stem cells´ properties can elucidate ways to 
expand stem cells correctly and control their differentia-
tion with precision.
Certainly, numerous studies with stem cells either men-
tioned or not in this article, have come up to date based 
on the experimental work in cell culture or animal mo-
dels. Regarding animal models, it is essential to unders-
tand that the results these studies provide have a limi-
ted validity when it comes to drawing conclusions for 
the treatment of our patients. Of course, some species 
of animals such as primates are best suited for studies 
than others, as for example mice, and obviously the first 
help us more to understand the behavior of stem cells in 
humans (27). With this in mind, even though being es-
sential for a better understanding on this complex field, 
it is clear that the results of those articles cannot be ex-
trapolated directly to humans.
Technical challenges
The challenges that still need to be solved are related 
to cell manipulation, biomaterials that serve as support 
and conduction systems of these components (35). First, 
the culture conditions have not been sufficiently deve-
loped as to imitate the biological niche that surrounds 
the stem in cells in vivo, and also to ensure that both cell 
proliferation and differentiation can occur in a safe and 
consistent way. On the other hand, as the cell culture 
medium often requires products group (such as fetal bo-
vine serum or mouse feeder layers), cultured cells may 
not be completely free of pathogens, with the possible 
risk of infection. Therefore, the establishment of optimal 
culture conditions without a potential cross-contamina-
tion is essential in the production of human stem cells 
for clinical use and the development of basic research 
involving the regulation of their self-renewal and the de-
termination of lineage (51).
Secondly, time is an inherent limitation in cell therapy 
and tissue engineering. Some autologous designs can 
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involve weeks or months of ex vivo processing. Althou-
gh the use of stem cells can often minimize processing 
time compared with somatic cells, the potential insta-
bility, karyotype and genetic mutations of cells after a 
long cultivation media can also limit their usefulness. 
Moreover, the search for the ideal biomaterials support 
and the system of driving stem cells is an important tech-
nical factor. The ideal material that serves as scaffolding 
must imitate the extracellular matrix that surrounds the 
cell, serve as support to the union of materials, allow the 
controlled release of bioactive factors, be conducive for 
the growth of the tissue and facilitate the manipulation 
in laboratory (52). Therefore, improvements in the me-
thodology are necessary to incorporate the stem cells to 
the defects on the oral structures, along with the goal of 
minimizing the ex vivo processing time and promote the 
integration and functioning of the implanted cells with 
cells belonging to the patient.
-Clinical challenges 
The clinical challenges facing stem cells in oral regene-
rative therapies are related to a possible immune rejec-
tion after their administration, oncogenic properties of 
stem cells and the integration of tissue transplanted to 
the patient (51). It is important to understand how the 
immune system can respond to a transplant of stem cells 
or their derivatives. In general, the immunogenicity of a 
human cell depends on its expression of the major his-
tocompatibility complex antigen class I and II, allowing 
the body to differentiate their own cells from foreign 
cells. Stem cells from human embryos express a low le-
vel of major histocompatibility complex antigens class I, 
but this expression is regulated to differentiation.
A potential solution to this problem could be in the use 
of autologous stem cells (from cells or tissue banks) to 
overcome immune rejection. Recently, the research of S. 
Yamanaka led to the production of patient-specific IPS 
cells, also known as induced pluripotent stem cells that 
are extracted from adult somatic cells. However, diffe-
rentiation of IPS into certain cell types for transplanta-
tion is still being studied. The recent findings related to 
immunosuppression of both in vitro and in vivo mesen-
chymal stem cells have also raised the possibility using 
allogeneic stem cells without the need of a donor and 
receptor (27). 
The challenge in relation to genomic stability and risk 
of tumor transformation after a stem cell transplant are 
major concerns in terms of safety, as there are no reliable 
methods to eliminate undifferentiated embryonic stem 
cells from the culture medium, and current studies lack 
long-term follow-up to draw firm conclusions yet. Most 
probably, the more specific the therapeutic application 
is, the longer should stem cells remain in vitro. During 
this long period in culture media, it is more probable that 
genetic or epigenetic changes in stem cells take place. 
Therefore, a better understanding of such in vitro chan-
ges will enable a better perception of the risk of tumor 
genesis in stem cell therapy (35).
Finally, it is not clear whether human stem cells can be 
integrated and able to perform the specific functions of 
lost or damaged tissues. It will be necessary to confirm 
that stem cells are transformed into stable cells showing 
the characteristics and functions of normal host cells 
after their transplantation. Hopefully, as a result of the 
advancement of our knowledge about stem cells, growth 
factors and cells support systems, a safe and effective 
cell therapy is expected in the near future.
-Other difficulties
According to Louis Lin et cols. in a review of the lite-
rature published on periapical surgery and guided tissue 
regeneration (34,54), it is not possible to correctly per-
form a meta-analysis in this area due to the wide varia-
tions in the methodology of the research. This happens 
in different types of therapies that are mentioned in the 
text, focusing especially on stem cells. 
In a meta-analysis performed in relation to the possible 
application of stem cells in sinus floor elevation surge-
ries (9), authors describe it as an area with deficient qua-
lity of studies. An example is that they did not find publi-
shed randomized clinical trials in patients being studied 
for both sinuses. In addition, reported studies showed 
test groups and without any kind of control group. Most 
studies were performed on a small number of patients 
and still have a short follow-up (38).
Which conditions should the microenvironment su-
rrounding stem cells ideally have so that they perform 
their activity in an effective and safe  way for the pa-
tient?
To apply the therapy based on cells in the treatment of 
diseases, it is necessary to identify the properties that the 
microenvironment surrounding them must own (55). It 
is well known that cell niche highly influences on the 
behavior of stem cells, thus the appropriate microenvi-
ronment provides their optimal performance. These qua-
lities are summarized in six points as Reddi et al (56) 
propose:  
1. The microenvironment surrounding stem cells must 
increase their survival cells in the receiving area.
2. It must be capable of integrating the transplanted cells 
without causing damage to the receiver. We need to find 
strategies to prevent the problem of immune rejection 
without using immunosuppressive medication.
3. Increase the proliferative activity of stem cells to ge-
nerate enough tissue.
4. Induce the differentiation of stem cells in the desired 
cell types.
5. Capable of preserving the cells in that tissue and to 
continue their activities throughout the life of the patient 
subject to transplantation.
6. Should identify the unwanted cells and be able to eli-
minate them.
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What future does cell therapy offer? 
Most articles agree to assert that the future of stem cell 
therapy is promising. However, as occurs with other 
new technologies, there are many issues that we have to 
solve. It is now time to move from studies on animals, 
which are now offering evidence of sufficient safety, to 
conduct clinical trials of cell therapy on patients. So far, 
studies on patients are scarce and in few groups of in-
dividuals; not enough to obtain statistically significant 
data. The considerable amount of studies carried out on 
animals provides an overwhelming amount of evidence 
that supports the use of mesenchymal stem cells in surgi-
cal procedures as in the case of periodontal regeneration.
However, there are critical steps in the establishment of 
these treatments to for our patients. Problems mentioned 
that still need to be solved, mainly related to the suitable 
carriers for them, are: immunogenicity, allogeneic or auto-
logous stem cell source, along with choosing the best do-
nor region, and the control of the global process, without 
forgetting the cost-benefit ratio. Therefore, before moving 
forward with confidence, we must pass through a critical 
phase to validate a systematic treatment with mesenchymal 
stem cells as a reliable source for therapeutic use. 
Finally, dentists interested in the application of cell 
therapy to their surgical practice would demand the 
existence of protocols as well as training in this field. 
Undoubtedly, in the near future there will be an abso-
lute necessity of the development of the infrastructures 
to process this technology with strict protocols of good 
manufacturing procedures. 
Conclusions
Research conducted in the field of stem cells has been a 
revolution in the international scientific community, as 
an opportunity in dentistry regarding the need of new re-
generative technologies. The current regenerative treat-
ments do not provide desirable results; require long pe-
riods of pause, and a lack of good clinical predictability.
Hopefully, mesenchymal stem cells are the flagship of 
the regeneration therapies of tissues. The opportunity of 
using stem cells has been brought to oral surgery with 
the discovery of different sources of adult stem cells in 
oral tissues, as the periodontal ligament or the dental 
pulp, with the advantage of being easily accessible to 
dentists. 
In various clinical applications mesenchymal stem cells 
have been used in combination with different matrix and 
growth factors, showing ability to form periodontal liga-
ment, alveolar bone, cartilage and cement in vivo.
Before becoming a realistic alternative in oral tissue 
regeneration, a thorough understanding concerning 
self-renewal and differentiation is essential, to overcome 
the biological, clinical and technical challenges, and the-
reby facilitate the manipulation of stem cells and their 
transfer to a clinical environment. 
Taking into account that most of the investigations have 
been limited to the experimental field on animal models, 
optimistic results must be extrapolated with caution to 
the clinical application on humans. In our field we still 
lack of controlled clinical trials with a high level of evi-
dence, so in the next few years there will be a process of 
trial and error before achieving the clinical protocols of 
the best materials and combinations.
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